Medicine and Dentistry
Patient
100%
Muscle
81%
Phosphotransferase
54%
Diseases
45%
Antibody
27%
Myasthenia gravis
27%
Age
18%
Diagnosis
18%
Weakness
18%
Limb
18%
Surgery
9%
Prevalence
9%
Phenotype
9%
Immunosuppressive Treatment
9%
Drug Therapy
9%
Muscle Weakness
9%
In Vitro
9%
Acetylcholinesterase
9%
Assisted Ventilation
9%
Onset Age
9%
Pyridostigmine
9%
Immunosuppressive Drug
9%
Thymus
9%
Receptor Antibody
9%
Repetitive Nerve Stimulation
9%
Symptom
9%
Immunoglobulin G Antibody
9%
Facial Muscle
9%
Agrin
9%
Edrophonium
9%
Neostigmine
9%
Observation
9%
Examination
9%
Man
9%
Woman
9%
Female
9%
Assay
9%
Injection
9%
Atrophy
9%
Neuroscience
Kinase
54%
Antibodies
27%
Myasthenia gravis
27%
Electromyography
18%
In Vitro
9%
Phenotype
9%
Pyridostigmine
9%
Thymus
9%
Receptor Antibody
9%
Immunoglobulin G Antibody
9%
Acetylcholinesterase Inhibitor
9%
Agrin
9%
Edrophonium
9%
Neostigmine
9%
Biochemistry, Genetics and Molecular Biology
Kinase
54%
Age
27%
Phenotype
9%
Prevalence
9%
Repetitive Nerve Stimulation
9%
Agrin
9%